Conmed (CNMD) Research & Development (2010 - 2026)
Conmed (CNMD) posted Research & Development of $16.3 million for Q1 2026, up 9.62% on a QoQ basis from $14.9 million in Q4 2025, and up 26.15% year-over-year from $12.9 million in Q1 2025.
Conmed (CNMD) Research & Development (2010 - 2026) Analysis & Trends
Conmed's Research & Development history runs 17 years deep, the most recent figure standing at $16.3 million for Q1 2026.
- Quarterly Research & Development rose 26.15% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.3 million (up 10.21% YoY) and the FY2025 annual result came in at $55.9 million, up 2.68% from the prior year.
- Research & Development was $16.3 million for Q1 2026 at Conmed, up from $14.9 million in the prior quarter.
- Across five years, Research & Development topped out at $16.3 million in Q1 2026 and bottomed at $10.7 million in Q1 2022.
- A 5-year average of $13.3 million and a median of $13.6 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development decreased 6.07% — and 2026, when it climbed 26.15%.
- Conmed's Research & Development stood at $12.2 million in 2022, then rose by 14.8% to $14.0 million in 2023, then dropped by 6.07% to $13.2 million in 2024, then advanced by 13.08% to $14.9 million in 2025, then gained by 9.62% to $16.3 million in 2026.
- Business Quant data shows CNMD's Research & Development at $16.3 million in Q1 2026, $14.9 million in Q4 2025, and $13.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 16.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.33 Mn |
| Dec 31, 2025 | 14.90 Mn |
| Sep 30, 2025 | 13.90 Mn |
| Jun 30, 2025 | 14.14 Mn |
| Mar 31, 2025 | 12.95 Mn |
| Dec 31, 2024 | 13.18 Mn |
| Sep 30, 2024 | 13.56 Mn |
| Jun 30, 2024 | 14.10 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 14.03 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 13.57 Mn |
| Mar 31, 2023 | 12.54 Mn |
| Dec 31, 2022 | 12.22 Mn |
| Sep 30, 2022 | 12.77 Mn |
| Jun 30, 2022 | 11.49 Mn |
| Mar 31, 2022 | 10.67 Mn |
| Dec 31, 2021 | 11.36 Mn |
| Sep 30, 2021 | 10.86 Mn |
| Jun 30, 2021 | 11.32 Mn |